Market Chatter: WW Plans to Offer Wegovy Pill After Launch

MT Newswires Live11-14

WW International (WW) plans to offer Novo Nordisk's (NVO) Wegovy in pill form if it is launched in the US next year, Reuters reported Wednesday, citing WW CEO Tara Comonte.

"We have been working with Novo Nordisk ahead of time to support the launch of oral weight-loss medication," Comonte was quoted as saying in an interview.

"A lot of people don't want an injection. And the convenience of a pill is going to be huge," she said.

WW did not immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 27.88, Change: +0.09, Percent Change: +0.34

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment